February 23, 2018
- FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy - mp3 file
- FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy – Transcript
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Shortages
- Amiodarone Tablets (New - Discontinuation)
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated - Currently in Shortage)
- Carbidopa and Levodopa Extended Release Tablets (Updated - Currently in Shortage)
- Fluoxetine Capsules (New - Discontinuation)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Triamterene and Hydrochlorothiazide Tablets (New - Discontinuation)
- Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials
- National Drug Code Directory (updated)
- Q11 Development and Manufacture of Drug Substances--Questions and Answers (Chemical Entities and Biotechnological/Biological Entities (PDF-843KB)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario